Core Viewpoint - Company is recognized as a global leader in collaborative robots and embodied intelligence solutions, with a strong outlook for continued commercial validation and growth [1][2] Group 1: Market Position and Performance - Company holds a 13% market share in the global collaborative robot shipment, ranking second globally and first in China, with over 80,000 units shipped across more than 15 industries [2][4] - Expected revenue for 2024 is projected at 374 million yuan, representing a year-on-year growth of 30.3%, while adjusted net loss is anticipated to narrow by 55.4% to 36.5 million yuan [2][5] Group 2: Industry Trends and Opportunities - The collaborative robot industry is poised for significant growth driven by the "AI + flexible manufacturing" trend, with a projected market size of $5 billion by 2028 and a compound annual growth rate (CAGR) of 37% from 2023 to 2028 [3] - Emerging applications in commercial, medical, and educational sectors are expected to grow faster than traditional industrial applications [3] Group 3: Competitive Advantages - Company boasts a comprehensive technology stack, achieving 100% localization of core components, and has significantly improved training efficiency for AI tasks [4] - Product offerings include a wide range of robots, with the humanoid robot Dobot Atom set to launch at a starting price of 199,000 yuan in 2025 [4] - Production capacity is robust, with a facility capable of producing 100,000 units annually and achieving high quality standards [4] Group 4: Financial Projections and Valuation - Revenue forecasts for 2025-2027 are 500 million, 670 million, and 890 million yuan, with respective year-on-year growth rates of 34%, 33%, and 33% [5] - Current stock price is projected to be in the range of 48.50 to 98.77 HKD based on relative and absolute valuation metrics [5]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [1][3]. Core Viewpoints - The company is a leading domestic collaborative robot manufacturer and is entering the humanoid robot sector with the launch of Dobot Atom in 2025, which is the world's first humanoid robot capable of "dexterous manipulation and bipedal walking" [1][6]. - The collaborative robot market has significant growth potential, with a projected CAGR of 30% in sales, while the company has shown a strong performance in the domestic market, ranking first in shipment volume in 2023 [6][37]. - The company possesses a comprehensive technology development capability and has self-developed SafeSkin technology, enhancing product safety and performance [6][56]. Financial Data and Valuation - The company is expected to achieve total revenue of 499 million yuan in 2025, with a year-on-year growth of 34% [2]. - The projected net profit for 2025 is -79 million yuan, with an improvement in losses expected in subsequent years [2]. - The company’s earnings per share are forecasted to be -0.20 yuan in 2025, improving to 0.02 yuan by 2027 [2]. Market Position and Product Performance - The company ranked second globally in collaborative robot shipments in 2023, with a market share of approximately 13% [6][49]. - The product lineup includes a wide range of collaborative robots, with a focus on six-axis models, which are becoming the main revenue driver [16][18]. - The company’s six-axis collaborative robots have a gross margin of 47%, slightly lower than the 54.8% margin for four-axis models [18][25]. Growth Potential in Humanoid Robotics - The humanoid robot industry is entering a critical growth phase, with the global market expected to see a CAGR exceeding 80% from 2025 to 2035 [6][37]. - The Dobot Atom humanoid robot is anticipated to significantly contribute to the company's revenue growth due to its advanced capabilities [6][12]. Shareholder Structure and Management - The company has a concentrated ownership structure, with the chairman holding approximately 27.97% of the shares [28][29]. - The management team has a strong background in robotics and engineering, primarily from Shandong University [30][31].

Investment Rating - The report maintains an "Add" rating for the company [5] Core Views - The strategic cooperation agreement signed between the company and Yaoshi Bang aims to explore the application of intelligent robots in the pharmaceutical industry, focusing on areas such as drug research, storage, distribution, retail, and medication services [2] - The company has demonstrated strong generalization capabilities in its robots, which can effectively operate in the pharmaceutical environment, handling diverse drug specifications and performing tasks such as sorting and transporting medications [3] - The increasing deployment of humanoid robots in various industries, including automotive and energy, is expected to accelerate their mass production and commercialization [4] Financial Forecasts - The company’s revenue projections for 2025, 2026, and 2027 are estimated at 4.96 billion, 6.73 billion, and 8.97 billion respectively, with corresponding price-to-sales ratios of 46, 34, and 25 [5] - The net profit for 2025 is projected to be a loss of 43.49 million, turning positive in 2026 with a profit of 1.15 million and reaching 34.54 million in 2027 [5] - The earnings per share (EPS) is expected to improve from a loss of 0.11 in 2025 to a profit of 0.09 in 2027 [5]

Investment Rating - The report maintains an "Add" rating for the company [5] Core Views - The strategic cooperation agreement between the company and Yaoshi Bang aims to explore the application of intelligent robots in the pharmaceutical industry, focusing on areas such as research, warehousing, distribution, retail, and medication services [2] - The company has demonstrated strong generalization capabilities in its robots, which can adapt to various tasks in the pharmaceutical environment, including sorting and transporting medications [3] - The increasing deployment of humanoid robots in various industries is expected to accelerate their mass production and commercialization [4] Financial Forecasts - The company’s revenue projections for 2025, 2026, and 2027 are estimated at 4.96 billion, 6.73 billion, and 8.97 billion respectively, with corresponding price-to-sales ratios of 46, 34, and 25 [5] - The net profit for 2025 is projected to be a loss of 43.49 million, with a turnaround expected in 2026, achieving a profit of 1.15 million, and further increasing to 34.54 million in 2027 [5] - The earnings per share (EPS) is expected to improve from a loss of 0.11 in 2025 to a profit of 0.09 in 2027 [5]

华为将依托全栈AI基础设施能力，支持优必选建设具身智能创新中心，并基于场景打造"人形机器人 +智慧工厂"联合示范方案，开发家庭服务人形机器人(包含双足和轮式人形机器人)等方面展开合作。 近年来，华为加速人形机器人领域的布局。2024年6月21日，华为开发者大会(HDC2024)在东莞松山湖 开幕。会上发布了盘古大模型5.0，并展示了乐聚夸父人形机器人搭载盘古具身智能大模型后在工业、 家庭场景中的泛化潜力，引起广泛关注。日前，华为旗下投资平台哈勃科技接连入股具身智能机器人研 发商千寻智能与工业软件企业同元软控，进一步拓展其在人工智能与高端制造领域的战略版图。 华为+优必选，腾讯云+越疆，本土大厂纷纷携手人形机器人深企，前日多个协议签订，加速具身智能 技术创新及多场景应用落地。 华为支持优必选 建设具身智能创新中心 5月12日，华为与优必选科技在深圳正式签署全面合作协议。双方将围绕具身智能和人形机器人领域， 在产品技术研发、场景应用及产业体系等开展创新合作。 协议约定，双方将通过发挥华为昇腾、鲲鹏、华为云及大模型等能力与华为在研发、生产供应等经验， 结合优必选全栈式人形机器人技术，推动人形机器人从实验室创新向工业 ...

Financial Performance - For the fiscal year ending December 31, 2024, the company reported a revenue of RMB 373,678,000, representing a 30.3% increase from RMB 286,749,000 in 2023[16] - The gross profit for 2024 was RMB 173,979,000, up from RMB 124,844,000 in 2023, indicating a gross margin improvement[16] - The company reported a net loss attributable to shareholders of RMB 95,363,000 for 2024, a slight improvement from RMB 103,281,000 in 2023[16] - The net loss for 2024 was RMB 95.4 million, a reduction of 7.6% from 2023, while the adjusted net loss was RMB 36.5 million, down 55.4% year-over-year[18] - The group's net loss for the year was approximately RMB 95.4 million, a decrease of about 7.6% from RMB 103.3 million in 2023[57] - The adjusted net loss (non-IFRS measure) for the year was RMB 36.5 million, a reduction of 55.4% compared to RMB 81.8 million in 2023, due to increased revenue and improved operational efficiency[59] Assets and Liabilities - The total assets increased significantly to RMB 1,495,208,000 in 2024, compared to RMB 734,888,000 in 2023, reflecting a growth of 103.5%[16] - The total liabilities increased to RMB 527,919,000 in 2024, up from RMB 361,585,000 in 2023, indicating a rise in financial obligations[16] - Shareholders' equity increased from RMB 373.3 million as of December 31, 2023, to RMB 967.3 million as of December 31, 2024, primarily due to the IPO leading to an increase in share capital and share premium of RMB 662.8 million[60] Market Position and Innovation - The company has achieved a cumulative global shipment of over 80,000 collaborative robots, ranking first in China and among the top two globally[10] - The introduction of the AI+Robot training platform X-Trainer marks a significant innovation, making the company the first to commercialize AI in collaborative robots[12] - The company has established over 200 application scenarios in the industrial sector, enhancing its capabilities in commercial and medical fields[10] - As of 2024, more than 80 Fortune 500 companies are utilizing the company's robots, demonstrating strong market validation[13] - The company has achieved a significant technological breakthrough with the launch of a visual-guided flexible connector assembly solution, enhancing automation in 3C electronic manufacturing[19] - The company has developed the X-Trainer, the world's first commercial AI-enabled collaborative robot, enhancing autonomous learning and operational efficiency[27] Revenue Breakdown - Sales revenue from six-axis collaborative robots was approximately RMB 208.9 million in 2024, up 55.5% from RMB 134.3 million in 2023, due to increased application demand across various industries[39] - Sales revenue from composite robots increased by approximately 64.7% to RMB 56.5 million in 2024, compared to RMB 34.3 million in 2023, driven by sales in manufacturing and retail sectors[41] - Revenue from industrial applications rose by 32.3% to RMB 200.0 million in 2024, up from RMB 151.2 million in 2023, due to steady growth in target markets and enhanced robot functionalities[44] - Revenue from the education sector increased by 19.7% to RMB 146.5 million in 2024, compared to RMB 122.4 million in 2023, driven by improved market penetration of related products[45] - Revenue from the commercial sector surged by 111.6% to RMB 25.6 million in 2024, up from RMB 12.1 million in 2023, attributed to new product launches and increased contracts in the food and beverage market[46] Corporate Governance - The company is committed to high standards of corporate governance to protect shareholder interests and enhance corporate value and accountability[88] - The board of directors is responsible for leading and controlling the group, overseeing business strategy and performance, and ensuring compliance with applicable laws and regulations[94] - The company has adopted the corporate governance code as per the listing rules since its listing date and has complied with all applicable provisions during the reporting period[88] - The board currently consists of a balanced composition of executive, non-executive, and independent non-executive directors, ensuring diverse expertise and independent judgment in decision-making[96] - The company has implemented policies to promote a diverse and safe workplace, emphasizing the importance of safety in operations[90] Employee and Director Information - As of December 31, 2024, the company has a total of 416 male employees and 144 female employees, achieving gender diversity in its workforce[118] - The board consists of seven members, including one female member, resulting in a gender diversity rate of 14.3%[120] - The group employed 560 staff, an increase from 552 in 2023, with total employee costs amounting to approximately RMB 161.8 million compared to RMB 132.6 million in the previous year[187] - The board of directors and senior management's compensation is determined based on their responsibilities, experience, and individual performance, with adjustments made based on recommendations from the remuneration and assessment committee[190] Risk Management and Compliance - The company has implemented an effective risk management and internal control system to manage risks associated with daily operations and achieve business objectives[128] - The internal control system includes risk identification, assessment, management strategies, and monitoring activities to ensure compliance and operational effectiveness[130] - The company has a zero-tolerance policy towards corruption, including bribery and fraud, and has implemented internal reporting channels for employees[140] - The board emphasizes the importance of transparent and timely communication with shareholders to enhance investor relations[145] Financing and Capital Structure - The company issued 358,038,547 H-shares at a price of HKD 18.8 per share, raising approximately HKD 681.4 million in net proceeds from the global offering[162] - The allocation of the net proceeds includes 40.0% (approximately HKD 272.6 million) for the development of smart collaborative robots from 2025 to 2029[163] - The company plans to utilize the proceeds for production line and manufacturing capacity development, accounting for 27.0% (approximately HKD 184.0 million) of the total[163] - The company does not recommend the payment of a final dividend for the year ended December 31, 2024[167] Shareholder Information - The company's largest customer accounted for approximately 5.1% of total revenue for the year ending December 31, 2024, compared to 3.5% in 2023[175] - The total revenue from the top five customers represented about 16.5% of total revenue for the year ending December 31, 2024, up from 12.8% in 2023[175] - The total procurement amount from the largest supplier and subcontractor accounted for approximately 14.7% of total procurement for the year ending December 31, 2024, compared to 13.7% in 2023[175]

未来的业绩展望我们第三个环节会把时间交给线上的各位投资人来跟公司的管理层来进行问答和交流我们首先就进入到第一个环节我们首先有请首席财务官王勇总来跟我们做2024年度月江机器人的业绩的分享好的 谢谢各位投资人大家晚上好首先感谢大家参加我们晚上发布的业绩交流 首先我们回顾一下R7.0的基因数据首先是我们这个营业收入是3.74亿人民币增幅是30.3%从R3.0的增幅是19%这个比R3.0的增幅是大大加快了我们按照这个输入这个类型来看我们分了六轴 四轴和复活机器人那么六轴增长幅度是56% 四轴略微有一些下降复合机器人也是大幅增长65%从细分领域来看六轴因为我们广泛应用于工业场景和商业场景那么工业场景经过几年的打磨我们客户的基础是比较多的那么很多从测试走向小批量以及放量所以有加速增长的趋势 四轴略微下降主要是四轴我们有面向工业的和科研教育领域的四轴产品那么四轴在科研教育领域我们在23年推出了六轴产品那么六轴在24年有发量产生了一定的替代效应虽然数量有所下降但整个我们面向科研教育的输入也是有20%增长 另外是复合机器人,复合机器人整体上增长了65%,这里面主要是由咖啡机器人以及巨声智能。去年我们在2014年4月份,在整个 ...

证券研究报告·海外公司深度·软件服务(HS) 越疆（02432.HK） 协作机器人龙头企业，切入具身智能赛道焕 新机 增持（首次） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 286.75 | 373.68 | 496.41 | 672.80 | 896.94 | | 同比(%) | 18.98 | 30.32 | 32.84 | 35.53 | 33.32 | | 归母净利润（百万元） | (103.28) | (95.36) | (43.49) | 1.15 | 34.54 | | 同比(%) | (96.81) | 7.67 | 54.40 | 102.65 | 2,893.76 | | EPS-最新摊薄（元/股） | (0.26) | (0.24) | (0.11) | 0.00 | 0.09 | | P/E（现价&最新摊薄） | (265.17) | (287.19) | (629.79) | 23,736.49 ...

Investment Rating - The report assigns an "Accumulate" rating for the company, marking the first coverage of the stock [1]. Core Insights - The company has established itself as a leader in the collaborative robot sector and is now venturing into the embodied intelligence field, creating new growth opportunities [11]. - The collaborative robot market is projected to grow significantly, with a compound annual growth rate (CAGR) of 36.6% from 2023 to 2028, indicating strong potential for future expansion [4][11]. - The company has a solid technological foundation with five core competencies that create a competitive moat, including key component design, a universal control platform, safety technology, robotic technology, and AI capabilities [4][48]. Summary by Sections Company Overview - Founded in 2015, the company has focused on collaborative robots and has grown to become an industry leader, with a revenue increase from 174 million yuan in 2021 to 374 million yuan in 2024, achieving a CAGR of 29.1% [3][20]. - The company has expanded its product offerings across four main segments: six-axis collaborative robots, four-axis collaborative robots, composite robots, and embodied intelligent robots [3][16]. Market Potential - The collaborative robot market, while currently smaller in scale, is expected to see substantial growth, particularly in industrial applications, which remain the largest demand source [4][41]. - The company holds a market share of 13.0% in the collaborative robot sector, with a shipment volume of 14,000 units in 2023, significantly outperforming the third-largest competitor [4][45]. Financial Projections - Revenue forecasts for the company indicate growth from 4.96 billion yuan in 2025 to 8.97 billion yuan in 2027, with corresponding price-to-sales ratios of 46, 34, and 25 [11][59]. - The company is expected to narrow its net loss from 1.03 billion yuan in 2023 to 0.95 billion yuan in 2024, driven by increased shipments of six-axis and four-axis collaborative robots [3][20]. Technological Advancements - The company has launched the Dobot Atom, the world's first "dexterous operation + bipedal walking" embodied intelligent robot, which is expected to accelerate the commercialization of humanoid robots [5][51]. - The Dobot Atom features advanced AI capabilities and is designed for various applications, including household tasks and customer service roles [53][54].

Financial Performance - Revenue for the year reached RMB 373.7 million, an increase of 30.3% compared to RMB 286.7 million in 2023[5] - Loss attributable to equity shareholders decreased by 7.6% to RMB 95.4 million from RMB 103.3 million in 2023[5] - Adjusted net loss for the year was RMB 36.5 million, a significant reduction of 55.4% from RMB 81.8 million in 2023[5] - Gross profit for 2024 was RMB 174.0 million, a 39.4% increase from RMB 124.8 million in 2023, with a gross margin of 46.6%, up 3.1 percentage points from 43.5% in 2023[37] - The net loss for the year was approximately RMB 95.4 million, a decrease of about 7.6% compared to RMB 103.3 million in 2023[47] - The adjusted net loss (non-IFRS measure) attributable to equity shareholders was RMB 36.5 million, a reduction of 55.4% from RMB 81.8 million in 2023, due to increased revenue and improved operational efficiency[51] - Total revenue for 2024 was RMB 373.7 million, up from RMB 286.7 million in 2023, representing a growth of approximately 30.3%[57] - The basic and diluted loss per share for the year was RMB 0.26, compared to RMB 0.29 in 2023[58] Revenue Breakdown - Revenue from industrial applications rose by 32.3% to RMB 200.0 million in 2024, compared to RMB 151.2 million in 2023, driven by steady growth in target markets and enhanced functionality of collaborative robots[34] - Revenue from educational applications increased by 19.7% to RMB 146.5 million in 2024, up from RMB 122.4 million in 2023, due to improved market penetration of related products[35] - Revenue from commercial applications surged by 111.6% to RMB 25.6 million in 2024, compared to RMB 12.1 million in 2023, driven by the introduction of automated coffee stations and increased contracts in the food and beverage market[36] - Revenue from mainland China was RMB 172,738 thousand, up 47.2% from RMB 117,221 thousand in 2023[76] - Revenue from overseas (including Hong Kong, Macau, and Taiwan) was RMB 200,940 thousand, an increase of 18.6% from RMB 169,528 thousand in 2023[76] Research and Development - Research and development expenses were approximately RMB 71.8 million in 2024, a slight increase of 1.8% from RMB 70.5 million in 2023, attributed to improved R&D efficiency and new investments in embodied intelligent robots[44] - The company achieved a major technological breakthrough in July 2024 with the introduction of a vision-guided flexible connector assembly solution for precision assembly in 3C electronics[8] - The company plans to enhance its technology research and product innovation, focusing on safety, ease of use, flexibility, and ecological integration[19] Market Expansion and Product Development - The company launched 27 models across 4 series of robots, covering payloads from 0.25 kg to 20 kg, widely applied in various industries[11] - The company launched the X-Trainer, the first AI-enabled generalized training operation platform in the industry, in April 2024[16] - The company introduced the NOVA collaborative robot for integrated customer acupuncture and massage workstations, improving service quality and efficiency[14] - The company launched the Yueliang Robot Coffee Workstation in May 2024, automating the coffee-making process and supporting 24-hour continuous production[16] - The company aims to introduce larger payload and higher-speed robot products to meet diverse industrial needs[21] Financial Position and Assets - Cash and cash equivalents increased to RMB 883.8 million as of December 31, 2024, up RMB 772.8 million from RMB 111.0 million in 2023, primarily due to the IPO[54] - Total assets increased to RMB 1,495,208 thousand in 2024 from RMB 734,888 thousand in 2023, representing a growth of 103%[60] - Current assets rose significantly to RMB 1,252,040 thousand in 2024, up from RMB 501,852 thousand in 2023, marking a 149% increase[60] - The company's equity increased to RMB 967,289 thousand in 2024, up from RMB 373,303 thousand in 2023, indicating a growth of 159%[61] Liabilities and Expenses - Administrative expenses increased by 67.2% to RMB 88.8 million in 2024, mainly due to listing expenses of RMB 32.6 million incurred in 2024[43] - The company's total non-current liabilities decreased slightly to RMB 195,395 thousand in 2024 from RMB 200,788 thousand in 2023, a decline of 2.0%[61] - Current liabilities rose to RMB 332,524 thousand in 2024, compared to RMB 160,797 thousand in 2023, representing a growth of 106%[60] Corporate Governance and Compliance - The company plans to maintain a high level of corporate governance in line with the Hong Kong Stock Exchange's requirements[136] - The audit committee, consisting of three members, has reviewed the financial performance for the year ending December 31, 2024, ensuring compliance with applicable accounting standards and regulations[141] - The independent auditor, Ernst & Young, has agreed that the financial statements for the year ending December 31, 2024, are consistent with the group's draft financial statements[143] Market Risks and Future Outlook - The company faces various market risks, including interest rate fluctuations and changes in industry regulatory policies[127] - The company aims to deepen its overseas market presence and expand its global sales network[22] - The company will utilize the net proceeds from its IPO for R&D in advanced intelligent collaborative robot technology, production line upgrades, and strategic alliances[18]